Connection
David Simpson to Natalizumab
This is a "connection" page, showing publications David Simpson has written about Natalizumab.
|
|
Connection Strength |
|
 |
|
 |
|
0.021 |
|
|
|
-
Clifford DB, De Luca A, DeLuca A, Simpson DM, Arendt G, Giovannoni G, Nath A. Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol. 2010 Apr; 9(4):438-46.
Score: 0.021